Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer

Clinical Cancer Research

Volumn 11, Issue 19 I, 2005, Pages 6872-6879

  Stein, Torsten ^a   Price, Karen N ^c   Morris, Joanna S ^b   Heath, Victoria J ^a   Ferrier, Roderick K ^a   Bell, Alexandra K ^a   Pringle, Marie Anne ^a   Villadsen, René ^d   Petersen, Ole W ^d   Sauter, Guido ^e,f   Bryson, Gareth ^a   Mallon, Elizabeth A ^a   Gusterson, Barry A ^a,b  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; ANNEXIN A8; CYTOKERATIN 17; CYTOKERATIN 5; ESTROGEN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BASAL CELL; BREAST CANCER; BREAST HYPERPLASIA; CANCER INVASION; CANCER SURVIVAL; CARCINOMA IN SITU; COHORT ANALYSIS; DNA MICROARRAY; IMMUNOCYTOCHEMISTRY; INVASIVE CARCINOMA; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANIMALS; ANNEXINS; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MAMMARY GLANDS, ANIMAL; MICE; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 26444435798     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0547     Document Type: Article

References (45)

1. Fernandez MP, Copeland NG, Gilbert DJ, Jenkins NA, Morgan RO. The genetic origin of mouse Annexin VIII. Mamm Genome 1998;9:8-14.
2. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev 2002;82:331-71.
3. Gerke V, Creutz CE, Moss SE. Annexins: linking Ca(2+) signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005;6:449-61.
4. 2+/phospholipid binding protein that inhibits coagulation and phospholipase A2 activity. Its molecular cloning, expression and comparison with VAC-α. Eur J Biochem 1989; 185:63-71.
5. Brown NL, Knott L, Halligan E, et al. Microarray analysis of murine palatogenesis: temporal expression of genes during normal palate development. Dev Growth Differ 2003;45:153-65.
6. Sohma H, Ohkawa H, Akino T, Kuroki Y. Binding of annexins to lung lamellar bodies and the PMA-stimulated secretion of Annexin V from alveolar type II cells. J Biochem (Tokyo) 2001;130:449-55.
7. Rety S, Sopkova-de Oliveira Santos J, Dreyfuss L, et al. The crystal structure of Annexin A8 is similar to that of Annexin A3. J Mol Biol 2005;345:1131-9.
8. Bastian BC. Annexins in cancer and autoimmune diseases. Cell Mol Life Sci 1997;53:554-6.
9. Menell JS, Cesarman GM, Jacovina AT, et al. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 1999;340:994-1004.
10. Emoto K, Sawada H, Yamada Y, et al. Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res 2001;21:1339-45.
11. Theobald J, Hanby A, Patel K, Moss SE. Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells. Br J Cancer 1995;71: 786-8.
12. Srivastava M, Montagna C, Leighton X, et al. Haploinsufficiency of Anx7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the Anx7(+/-) mouse. Proc Natl Acad Sci U S A 2003;100:14287-92.
13. Chang KS, Wang G, Freireich EJ, et al. Specific expression of the Annexin VIII gene in acute promyelocytic leukemia. Blood 1992;79:1802-10.
14. Sarkar A, Yang P, Fan YH, et al. Regulation of the expression of Annexin VIII in acute promyelocytic leukemia. Blood 1994;84:279-86.
15. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406: 747-52.
16. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74.
17. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003; 100:8418-23.
18. van de Rijn M, Perou CM, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 2002;161:1991-6.
19. Stein T, Morris JS, Davies CR, et al. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004;6:R75-91.
20. Morris JS, Davies CR, Griffiths MR, et al. Proteomic analysis of mouse mammary terminal end buds identifies axonal growth cone proteins. Proteomics 2004;4: 1802-10.
21. Pechoux C, Gudjonsson T, Ronnov-Jessen L, Bissell MJ, Petersen OW. Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev Biol 1999;206:88-99.
22. Gudjonsson T, Villadsen R, Nielsen HL, et al. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 2002;16:693-706.
23. Kalbfleisch JD, RLP. The statistical analysis of failure time data. New York: John Wiley & Sons; 1980.
24. Gottsch JD, Seitzman GD, Margulies EH, et al. Gene expression in donor corneal endothelium. Arch Ophthalmol 2003;121:252-8.
25. Reutelingsperger CP, van Heerde W, Hauptmann R, et al. Differential tissue expression of Annexin VIII in human. FEBS Lett 1994;349:120-4.
26. White AH, Watson RE, Newman B, Freemont AJ, Wallis GA. Annexin VIII is differentially expressed by chondrocytes in the mammalian growth plate during endochondral ossification and in osteoarthritic cartilage. J Bone Miner Res 2002;17:1851-8.
27. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003;17: 1253-70.
28. Katoh N, Suzuki T, Yuasa A, Miyamoto T. Distribution of Annexins I, II, and IV in bovine mammary gland. J Dairy Sci 1995;78:2382-7.
29. Wheeler TT, Broadhurst MK, Rajan GH, Wilkins RJ. Differences in the abundance of nuclear proteins in the bovine mammary gland throughout the lactation and gestation cycles. J Dairy Sci 1997;80:2011-9.
30. Horlick KR, Ganjianpour M, Frost SC, Nick HS. Annexin-I regulation in response to suckling and rat mammary cell differentiation. Endocrinology 1991; 128:1574-9.
31. Croxtall JD, Choudhury Q, Newman S, Flower RJ. Lipocortin 1 and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGF stimulation of cPLA2 phosphorylation. Biochem Pharmacol 1996; 52:351-6.
32. Clarkson RW, Wayland WIT, Lee J, Freeman T, Watson CJ, Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 2004;6:R92-109.
33. Gerke V, Moss SE. Annexins and membrane dynamics, Biochim Biophys Acta 1997;1357:129-54.
34. Walker NI, Bennett RE, Kerr JF. Cell death byapoptosis during involution of the lactating breast in mice and rats. Am J Anat 1989;185:19-32.
35. Monks J, Geske FJ, Lehman L, Fadok VA. Do inflammatory cells participate in mammary gland involution? J Mammary Gland Biol Neoplasia 2002;7: 163-76.
36. Schwartz-Albiez R, Koretz K, Moller P, Wirl G. Differential expression of Annexins I and II in normal and malignant human mammary epithelial cells. Differentiation 1993;52:229-37.
37. Croxtall JD, Wu HL, Yang HY, et al. Lipocortin 1 co-associates with cytokeratins 8 and 18 in A549 cells via the N-terminal domain. Biochim Biophys Acta 1998;1401:39-51.
38. Dairkee SH, Ljung BM, Smith H, Hackett A. Immunolocalization of a human basal epithelium specific keratin in benign and malignant breast disease. Breast Cancer Res Treat 1987;10;11-20.
39. Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003;100:10393-8.
40. Seo HS, Journe F, Larsimont D, Sotiriou C, Leclercq G. Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatment. Steroids 2003;68:257-69.
41. Gusterson BA, Heath VJ, Ross DT, Stein T. Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer. Breast Cancer Res 2005;7:143-8.
42. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6:17-32.
43. Abd El-Rehim DM, Pinder SE, Paish CE, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 2004;203:661-71.
44. Osin P, Lu YJ, Stone J, et al. Distinct genetic and epigenetic changes in medullary breast cancer. Int J Surg Pathol 2003;11:153-8.
45. Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003;95: 1482-5.